We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy
Evidence-based coverage of pharmaceutical development, regulatory affairs, and biotech innovation
Introduction As the dust from the COVID-19 pandemic begins to settle, one industry that continues to command strong levels of public trust and favourability is pharmaceuticals. According to the third
By Dr. Eleanor Vance, Regulatory Affairs Editor
In today's rapidly advancing world, biotechnology has emerged as a powerful force, propelling medical science into uncharted territories and promising a brighter future for healthcare. This multidisci
By Dr. Eleanor Vance, Regulatory Affairs Editor
As the world becomes increasingly reliant on pharmaceuticals to treat a wide range of diseases, the importance of drug research and development (R&D) continues to grow. In recent years, there have
By Tom Okafor, Clinical Trials Correspondent
The pharmaceutical industry has seen a significant rise in the demand for biologics, which are drugs produced from living organisms. As the demand for biologics continues to grow, so does the need for
By Dr. Eleanor Vance, Regulatory Affairs Editor
Subscribe to our weekly pharmaceutical intelligence digest